1. American Society for Testing and Materials (ASTM) International, Standard practice for marking medical devices and other items for safety in magnetic resonance environments, F2503-05
  2. Maceira AM, Prasad SK, Khan M, Pennell DJ. Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2006; 8(3):417-26.
  3. Maceira AM, Prasad SK, Khan M, Pennell DJ. Reference right ventricular systolic and diastolic function normalized to age, gender and body surface area from steady-state free precession cardiovascular magnetic resonance.Eur Heart J. 2006 Dec; 27(23):2879-88. Epub 2006 Nov 6.
  4. Burman ED, Keegan J, Kilner PJ. Aortic root measurement by cardiovascular magnetic resonance: specification of planes and lines of measurement and corresponding normal values. Circ Cardiovasc Imaging. 2008; 1(2):104-13.
  5. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002; 105(4):539-42.
  6. Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J. 2010; 31(7):806-14.
  7. Friedrich MG, Sechtem U, Schulz-Menger J, et al. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol. 2009; 53(17):1475-87.
  8. Motwani M1, Kidambi A, Herzog BA, et al. MR imaging of cardiac tumors and masses: a review of methods and clinical applications. Radiology. 2013; 268(1):26-43
  9. Acute Myocardial Infarction in patients presenting with ST-segment elevation (Management of). ESC Clinical Practice Guidelines 2012
  10. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases. ESC Clinical Practice Guidelines 2014
  11. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy. ESC Clinical Practice Guidelines 2014
  12. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. ESC Clinical Practice Guidelines 2012
  13. 2013 ESC guidelines on the management of stable coronary artery disease. ESC Clinical Practice Guidelines 2013
  14. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases. ESC Clinical Practice Guidelines 2015
  15. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. ESC Clinical Practice Guidelines 2015
  16. Dungu JN, Valencia O, Pinney JH, et al. CMR-based differentiation of AL and ATTR cardiac amyloidosis. JACC Cardiovasc Imaging. 2014 Feb;7(2):133-42.
  17. Friedrich MG, Sechtem U, Schulz-Menger J, et al. International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol. 2009 Apr 28; 53(17):1475-87.
  18. Vermes E, Carbone I, Friedrich MG, Merchant N. Patterns of myocardial late enhancement: typical and atypical features. Arch Cardiovasc Dis. 2012 May; 105(5):300-8.
  19. Satoh H, Sano M, Suwa K, et al. Distribution of late gadolinium enhancement in various types of cardiomyopathies: Significance in differential diagnosis, clinical features and prognosis. World J Cardiol. 2014 Jul 26; 6(7):585-601.
    20.